Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Breast Cancer Res. 2024 Mar 26;26(1):53. doi: 10.1186/s13058-024-01814-9.

Jing Qian^{1

2}, Yanxia Ma^{1

3}, William M Tahaney^{1

4

5}, Cassandra L Moyer¹, Amanda Lanier¹, Jamal Hill¹, Darian Coleman¹, Negar Koupaei^{1

6}, Susan G Hilsenbeck⁷, Michelle I Savage¹, Brent D G Page⁸, Abhijit Mazumdar¹, Powel H Brown^{9

10}

¹ Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
² The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA.
³ Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁴ Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.
⁵ Monte Rosa Therapeutics, Boston, USA.
⁶ Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁷ Lester and Sue Smith Breast Center and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
⁸ Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
⁹ Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. PHBrown@mdanderson.org.
¹⁰ Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA. PHBrown@mdanderson.org.

No abstract available

Publication types